Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Lupus Foundation Of America Web Chat Explores "Your Skin And Lupus"
Approximately two-thirds of the 1.5 million Americans living with lupus will develop some type of skin disease. Lupus is an autoimmune disease in which the immune system is unbalanced causing it to become destructive to any organ and tissue in the body. Skin disease in lupus can cause rashes or sores (lesions), most of which will appear on sun-exposed areas, such as a person"s face, ears, neck, arms, and legs. In addition, 40-70 percent of people with systemic lupus will find that their disease is made worse by exposure to ultraviolet (UV) rays from sunlight or artificial light. For this and other reasons, people with lupus are advised to take steps to protect themselves from exposure to UV light.
generic viagra online
Precision Imaging Ultrasound Software For Toshiba's Aplio XG Provides Unprecedented Image Clarity And Resolution
To help leading healthcare institutions increase productivity while improving patient care in diagnostic imaging, Toshiba America Medical Systems, Inc., has introduced Precision Imaging technology available on the Aplio™ XG ultrasound system. Precision Imaging technology acquires ultrasound images of unprecedented clarity and resolution, enabling users to see more clinical detail than ever before.
News of the day
In Parkinson's Fly Model, Dementia Induced And Blocked
Parkinson"s disease is well-known for impairing movement and causing tremors, but many patients also develop other serious problems, including sleep disturbances and significant losses in cognitive function known as dementia.
Health Insurance

Diabetic Retinopathy Stopped By Natural Compound

Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States. The research appears online this month in the journal Diabetes, a publication of the American Diabetes Association. The discovery of the compound"s function in inflammation and blood vessel formation related to eye disease means scientists can now develop new therapies - including eye drops - to stop diabetic retinopathy, a disease which affects as many as five million Americans with Type 1 and Type 2 diabetes. "There is no good treatment for retinopathy, which is why we are so excited about this work. This opens an entirely new area for pharmaceutical companies to target," said Jay Ma, the principal investigator on the project and a research partner at the OU Health Sciences Center, Dean A. McGee Eye Institute and the Harold Hamm Oklahoma Diabetes Center. Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in blood vessels of the retina, the light-sensitive tissue at the back of the eye. In some people with diabetic retinopathy, blood vessels may swell and leak fluid. In other people, abnormal new blood vessels grow on the surface of the retina. Over time, diabetic retinopathy can get worse and cause some vision loss or blindness. Oklahoma researchers found that this inflammation and leakage is caused by an imbalance of two systems in the eye. To restore balance, they delivered the new compound to cells using nanoparticle technology. The treatment in research models stopped the leakage, blocked inflammation and kept unwanted blood vessels from growing. Researchers are now testing the compound"s uses for cancer and age-related macular degeneration. Dr. Ma"s research is funded by the American Diabetes Association and the National Institutes of Health. Diane Clay University of Oklahoma


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009